Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders

Abnormalities of chromosome 7q are common in myeloid malignancies, but no specific target genes have yet been identified. Here, we describe the finding of homozygous EZH2 mutations in 9 of 12 individuals with 7q acquired uniparental disomy. Screening of a total of 614 individuals with myeloid disord...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ernst, Thomas (VerfasserIn) , Chase, Andrew J. (VerfasserIn) , Score, Joannah (VerfasserIn) , Hidalgo-Curtis, Claire E. (VerfasserIn) , Bryant, Catherine (VerfasserIn) , Jones, Amy V. (VerfasserIn) , Waghorn, Katherine (VerfasserIn) , Zoi, Katerina (VerfasserIn) , Ross, Fiona M. (VerfasserIn) , Reiter, Andreas (VerfasserIn) , Hochhaus, Andreas (VerfasserIn) , Drexler, Hans G. (VerfasserIn) , Duncombe, Andrew (VerfasserIn) , Cervantes, Francisco (VerfasserIn) , Oscier, David (VerfasserIn) , Boultwood, Jacqueline (VerfasserIn) , Grand, Francis H. (VerfasserIn) , Cross, Nicholas C. P. (VerfasserIn)
Dokumenttyp: Article (Journal) Editorial
Sprache:Englisch
Veröffentlicht: 4 July 2010
In: Nature genetics
Year: 2010, Jahrgang: 42, Heft: 8, Pages: 722-726
ISSN:1546-1718
DOI:10.1038/ng.621
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/ng.621
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/ng.621
Volltext
Verfasserangaben:Thomas Ernst, Andrew J. Chase, Joannah Score, Claire E. Hidalgo-Curtis, Catherine Bryant, Amy V. Jones, Katherine Waghorn, Katerina Zoi, Fiona M. Ross, Andreas Reiter, Andreas Hochhaus, Hans G. Drexler, Andrew Duncombe, Francisco Cervantes, David Oscier, Jacqueline Boultwood, Francis H. Grand & Nicholas C.P. Cross

MARC

LEADER 00000caa a2200000 c 4500
001 1846225310
003 DE-627
005 20230710132253.0
007 cr uuu---uuuuu
008 230525s2010 xx |||||o 00| ||eng c
024 7 |a 10.1038/ng.621  |2 doi 
035 |a (DE-627)1846225310 
035 |a (DE-599)KXP1846225310 
035 |a (OCoLC)1389794334 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Ernst, Thomas  |d 1976-  |e VerfasserIn  |0 (DE-588)129357685  |0 (DE-627)393983285  |0 (DE-576)297617737  |4 aut 
245 1 0 |a Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders  |c Thomas Ernst, Andrew J. Chase, Joannah Score, Claire E. Hidalgo-Curtis, Catherine Bryant, Amy V. Jones, Katherine Waghorn, Katerina Zoi, Fiona M. Ross, Andreas Reiter, Andreas Hochhaus, Hans G. Drexler, Andrew Duncombe, Francisco Cervantes, David Oscier, Jacqueline Boultwood, Francis H. Grand & Nicholas C.P. Cross 
264 1 |c 4 July 2010 
300 |a 5 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 25.05.2023 
520 |a Abnormalities of chromosome 7q are common in myeloid malignancies, but no specific target genes have yet been identified. Here, we describe the finding of homozygous EZH2 mutations in 9 of 12 individuals with 7q acquired uniparental disomy. Screening of a total of 614 individuals with myeloid disorders revealed 49 monoallelic or biallelic EZH2 mutations in 42 individuals; the mutations were found most commonly in those with myelodysplastic/myeloproliferative neoplasms (27 out of 219 individuals, or 12%) and in those with myelofibrosis (4 out of 30 individuals, or 13%). EZH2 encodes the catalytic subunit of the polycomb repressive complex 2 (PRC2), a highly conserved histone H3 lysine 27 (H3K27) methyltransferase that influences stem cell renewal by epigenetic repression of genes involved in cell fate decisions. EZH2 has oncogenic activity, and its overexpression has previously been causally linked to differentiation blocks in epithelial tumors. Notably, the mutations we identified resulted in premature chain termination or direct abrogation of histone methyltransferase activity, suggesting that EZH2 acts as a tumor suppressor for myeloid malignancies. 
650 4 |a Mutation 
650 4 |a Myeloproliferative disease 
650 4 |a Tumour suppressors 
700 1 |a Chase, Andrew J.  |e VerfasserIn  |4 aut 
700 1 |a Score, Joannah  |e VerfasserIn  |4 aut 
700 1 |a Hidalgo-Curtis, Claire E.  |e VerfasserIn  |4 aut 
700 1 |a Bryant, Catherine  |e VerfasserIn  |4 aut 
700 1 |a Jones, Amy V.  |e VerfasserIn  |4 aut 
700 1 |a Waghorn, Katherine  |e VerfasserIn  |4 aut 
700 1 |a Zoi, Katerina  |e VerfasserIn  |4 aut 
700 1 |a Ross, Fiona M.  |e VerfasserIn  |4 aut 
700 1 |a Reiter, Andreas  |d 1964-  |e VerfasserIn  |0 (DE-588)172629551  |0 (DE-627)697563766  |0 (DE-576)133488594  |4 aut 
700 1 |a Hochhaus, Andreas  |e VerfasserIn  |4 aut 
700 1 |a Drexler, Hans G.  |e VerfasserIn  |4 aut 
700 1 |a Duncombe, Andrew  |e VerfasserIn  |4 aut 
700 1 |a Cervantes, Francisco  |e VerfasserIn  |4 aut 
700 1 |a Oscier, David  |e VerfasserIn  |4 aut 
700 1 |a Boultwood, Jacqueline  |e VerfasserIn  |4 aut 
700 1 |a Grand, Francis H.  |e VerfasserIn  |4 aut 
700 1 |a Cross, Nicholas C. P.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Nature genetics  |d London : Macmillan Publishers Limited, part of Springer Nature, 1992  |g 42(2010), 8 vom: Aug., Seite 722-726  |h Online-Ressource  |w (DE-627)303393734  |w (DE-600)1494946-5  |w (DE-576)080887198  |x 1546-1718  |7 nnas  |a Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders 
773 1 8 |g volume:42  |g year:2010  |g number:8  |g month:08  |g pages:722-726  |g extent:5  |a Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders 
856 4 0 |u https://doi.org/10.1038/ng.621  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/ng.621  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230525 
993 |a Editorial 
994 |a 2010 
998 |g 172629551  |a Reiter, Andreas  |m 172629551:Reiter, Andreas  |d 60000  |d 61200  |e 60000PR172629551  |e 61200PR172629551  |k 0/60000/  |k 1/60000/61200/  |p 10 
999 |a KXP-PPN1846225310  |e 4325205993 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title_sort":"Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders","title":"Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders"}],"person":[{"given":"Thomas","family":"Ernst","role":"aut","display":"Ernst, Thomas","roleDisplay":"VerfasserIn"},{"family":"Chase","given":"Andrew J.","display":"Chase, Andrew J.","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Score, Joannah","roleDisplay":"VerfasserIn","role":"aut","family":"Score","given":"Joannah"},{"family":"Hidalgo-Curtis","given":"Claire E.","display":"Hidalgo-Curtis, Claire E.","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Bryant","given":"Catherine","display":"Bryant, Catherine","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Jones","given":"Amy V.","display":"Jones, Amy V.","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Waghorn","given":"Katherine","roleDisplay":"VerfasserIn","display":"Waghorn, Katherine","role":"aut"},{"role":"aut","display":"Zoi, Katerina","roleDisplay":"VerfasserIn","given":"Katerina","family":"Zoi"},{"family":"Ross","given":"Fiona M.","roleDisplay":"VerfasserIn","display":"Ross, Fiona M.","role":"aut"},{"family":"Reiter","given":"Andreas","display":"Reiter, Andreas","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","display":"Hochhaus, Andreas","roleDisplay":"VerfasserIn","given":"Andreas","family":"Hochhaus"},{"given":"Hans G.","family":"Drexler","role":"aut","roleDisplay":"VerfasserIn","display":"Drexler, Hans G."},{"display":"Duncombe, Andrew","roleDisplay":"VerfasserIn","role":"aut","family":"Duncombe","given":"Andrew"},{"display":"Cervantes, Francisco","roleDisplay":"VerfasserIn","role":"aut","family":"Cervantes","given":"Francisco"},{"given":"David","family":"Oscier","role":"aut","display":"Oscier, David","roleDisplay":"VerfasserIn"},{"family":"Boultwood","given":"Jacqueline","display":"Boultwood, Jacqueline","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Grand, Francis H.","roleDisplay":"VerfasserIn","role":"aut","family":"Grand","given":"Francis H."},{"roleDisplay":"VerfasserIn","display":"Cross, Nicholas C. P.","role":"aut","family":"Cross","given":"Nicholas C. P."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 25.05.2023"],"recId":"1846225310","language":["eng"],"origin":[{"dateIssuedDisp":"4 July 2010","dateIssuedKey":"2010"}],"id":{"eki":["1846225310"],"doi":["10.1038/ng.621"]},"name":{"displayForm":["Thomas Ernst, Andrew J. Chase, Joannah Score, Claire E. Hidalgo-Curtis, Catherine Bryant, Amy V. Jones, Katherine Waghorn, Katerina Zoi, Fiona M. Ross, Andreas Reiter, Andreas Hochhaus, Hans G. Drexler, Andrew Duncombe, Francisco Cervantes, David Oscier, Jacqueline Boultwood, Francis H. Grand & Nicholas C.P. Cross"]},"physDesc":[{"extent":"5 S."}],"relHost":[{"title":[{"title_sort":"Nature genetics","title":"Nature genetics"}],"pubHistory":["1.1992 -"],"part":{"text":"42(2010), 8 vom: Aug., Seite 722-726","volume":"42","extent":"5","year":"2010","issue":"8","pages":"722-726"},"titleAlt":[{"title":"Genetics"}],"disp":"Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disordersNature genetics","type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 02.03.05"],"recId":"303393734","language":["eng"],"origin":[{"dateIssuedKey":"1992","publisher":"Macmillan Publishers Limited, part of Springer Nature ; Nature America","dateIssuedDisp":"1992-","publisherPlace":"London ; New York, NY"}],"id":{"issn":["1546-1718"],"eki":["303393734"],"zdb":["1494946-5"]},"physDesc":[{"extent":"Online-Ressource"}]}]} 
SRT |a ERNSTTHOMAINACTIVATI4201